Unum denied my long-term disability claim on a fibromyalgia and chronic fatigue syndrome diagnosis after 22 months on claim despite an own-occupation provision, treating physician support, and a Social Security Disability award by citing the policy mental and nervous limitation in a 24-month proof-of-loss letter that mischaracterized the ICD-10 diagnoses. Forced reinstatement and back-payment of $84,600 plus attorney fees using the ERISA 503-1 administrative appeal framework, the treating physician evidence rule, and the mental and nervous limitation challenge. The five-element approach to LTD denials on chronic pain and fatigue diagnoses

Posting this because long-term disability denials on fibromyalgia, chronic fatigue syndrome, post-Lyme disease syndrome, ME/CFS, and similar chronic pain and fatigue diagnoses are one of the most common policyholder underpayment patterns in the LTD industry, and the framework for forcing carriers to honor own-occupation and any-occupation benefits is well-developed under ERISA and state-law frameworks but is poorly understood by most claimants. Background: my LTD claim filed in October 2023 covered a fibromyalgia diagnosis (ICD-10 M79.7) and comorbid chronic fatigue syndrome (ICD-10 G93.32) supported by a board-certified rheumatologist, a board-certified neurologist, and a pain management physician with 14 years of documented treatment history including trigger point examinations, conditioned pain modulation testing, polysomnography results showing alpha-wave intrusion, autonomic function testing, and a functional capacity evaluation (FCE) documenting an inability to sustain seated or standing positions for more than 22 minutes at a time without significant pain exacerbation and cognitive decline. My pre-disability occupation was senior software architect requiring sustained cognitive concentration, prolonged seated computer work, and meeting attendance. The LTD policy issued by Unum to my prior employer (a Fortune 500 financial services firm) provided 60 percent of pre-disability earnings to age 67 under the any-occupation definition after a 24-month own-occupation period, with a $14,800 monthly maximum benefit.

Unum paid the claim through the 24-month own-occupation period at $9,400 per month and then sent a denial letter at month 24 transitioning the claim to the any-occupation definition. The denial letter asserted: (1) the policy mental and nervous limitation capped benefits at 24 months on conditions "primarily mental or nervous in origin," (2) the fibromyalgia and chronic fatigue diagnoses were "subjective" and "self-reported" with no objective evidence of disability, (3) the treating physician opinions were "advocacy" rather than independent medical evidence, (4) an Unum-retained file-review physician (board-certified in occupational medicine, never examined the claimant) had opined that the claimant could perform "sedentary work with appropriate accommodations," (5) the Social Security Disability award (granted in 2024 with a finding of disability beginning the LTD claim date) was "based on different criteria" and was not binding on the LTD claim determination. This is the standard Unum playbook on chronic pain and fatigue denials at the 24-month transition point and produces denial in approximately 65 percent of cases at the own-occupation to any-occupation transition without aggressive appeal.

The five-element approach to LTD denials on chronic pain and fatigue diagnoses. First, the ERISA 503-1 administrative appeal framework. ERISA Section 503 and the implementing regulation at 29 C.F.R. Section 2560.503-1 require LTD plans to provide a full and fair review of denied claims including: (1) written notification with specific reasons, policy provisions, and additional information requirements, (2) 180-day claimant appeal period with right to submit additional evidence, (3) 45-day plan determination period (extendable to 90 days for special circumstances), (4) independent review by a person not involved in the initial decision, (5) consultation with appropriate medical professionals on medical issues. The administrative appeal is the dispositive procedural framework because the federal courts review LTD denials under the deferential abuse-of-discretion standard when the plan grants discretionary authority, meaning the claimant is largely limited to the administrative record assembled during the appeal. Build the appeal record with: comprehensive treating physician narratives addressing the carrier's specific denial bases, updated medical records covering the appeal period, additional objective testing (FCE, neuropsychological testing, polysomnography, autonomic function testing), vocational expert opinion on the inability to perform any occupation, and detailed responses to each adverse medical opinion in the file.

Second, the treating physician evidence rule and the file-reviewer challenge. The Supreme Court's decision in Black & Decker Disability Plan v. Nord eliminated the formal treating physician rule under ERISA, but treating physician evidence remains substantial when properly developed. The carrier's reliance on file-review physicians without examination is one of the most challengeable aspects of LTD denials and supports findings of arbitrary and capricious decision-making under Glenn v. MetLife and the conflict-of-interest analysis. Challenge the file-reviewer evidence by: documenting the file-reviewer's lack of examination, identifying specific factual errors or omissions in the file-reviewer report, citing the file-reviewer's failure to address treating physician opinions or specific medical evidence, identifying conflict-of-interest indicators (insurance industry employment history, percentage of opinions favorable to insurance industry, compensation structure), and providing independent medical examination (IME) by a qualified specialist supporting disability. Third, the mental and nervous limitation challenge. LTD policies typically limit benefits to 24 months on conditions "primarily mental or nervous in origin" but the application of this limitation to fibromyalgia, chronic fatigue syndrome, ME/CFS, post-Lyme syndrome, and similar conditions has been rejected by multiple federal courts when the diagnoses are supported by physical examination findings, objective testing, and recognized diagnostic criteria. Document the physical basis of the diagnoses by: providing trigger point examination findings (fibromyalgia), polysomnography showing alpha-wave intrusion (chronic fatigue syndrome and fibromyalgia), autonomic function testing showing POTS or autonomic dysfunction, conditioned pain modulation testing, neuropsychological testing showing cognitive deficits consistent with fibrofog or ME/CFS cognitive symptoms, and treating specialist opinion that the diagnoses are physical rather than mental or nervous.

Fourth, the Social Security Disability award analysis. Social Security Disability Insurance (SSDI) awards are not binding on LTD plan determinations but are significant evidence of disability and the LTD plan's failure to address the SSDI award supports findings of arbitrary and capricious decision-making. Several federal circuits (including the Sixth and Ninth Circuits) have held that LTD plans cannot ignore SSDI awards when the LTD plan has required the claimant to apply for SSDI as a condition of LTD benefits. Document the SSDI analysis by: providing the SSDI award letter and ALJ decision, identifying the LTD plan provision requiring SSDI application, citing the relevant Social Security medical-vocational guidelines, and demanding plan response to the SSDI determination. Fifth, the conflict-of-interest analysis under Glenn v. MetLife. The Supreme Court's decision in Metropolitan Life Insurance Co. v. Glenn requires courts to consider structural conflicts of interest in LTD claim determinations where the same entity both decides claims and pays benefits. Document the conflict by: identifying the plan administrator and the funding source, citing the carrier's financial incentive to deny claims, identifying the carrier's history of denial reversals and regulatory actions (Unum has been subject to multi-state regulatory settlements in 2004 and subsequent compliance monitoring), and arguing for reduced deference to the carrier's claim determination under Glenn. The Unum claim was reinstated with retroactive payment of $84,600 covering 9 months of denied benefits plus attorney fees of $32,400 following: (i) administrative appeal supported by treating physician narratives, IME by a qualified rheumatologist, vocational expert opinion, and detailed responses to each Unum medical opinion in the file, (ii) federal lawsuit filed under ERISA Section 502(a)(1)(B) in the Northern District of California after appeal denial, (iii) summary judgment motion supported by the administrative record and conflict-of-interest analysis, (iv) mediated settlement during summary judgment briefing. Total recovery: $117,000 plus reinstated monthly benefits at $9,400 per month to age 67. The ERISA administrative appeal framework and the conflict-of-interest analysis under Glenn were the dispositive procedural frameworks, and the mental and nervous limitation challenge was decisive on the substantive disability determination.